Advertisement
ADC Therapeutics Appoints Jose Carmona To Succeed Jenn Creel As CFO
(RTTNews) - ADC Therapeutics SA (ADCT) announced Monday the appointment of Jose "Pepe" Carmona as Chief Financial Officer (CFO), effective December 19, 2022. He will serve on the Company's executive leadership team and succeeds Jenn Creel, who is leaving to pursue other opportunities.
Carmona is a seasoned CFO with over 20 years of leadership, commercial and partnership experience in the pharmaceutical industry, both in the U.S. and internationally.
He most recently served as CFO of Rubius Therapeutics where he was responsible for all financial functions as well as business development, investor relations, information technology and procurement.
Prior to joining Rubius, Carmona was the CFO of Radius Health and Innocoll. During his 12 years at Novartis, Carmona held financial management positions with increasing responsibilities in various divisions and geographies, including CFO Alcon for Europe, Middle East and Africa.
Euro Rises Against Majors
German Industrial Output Declines Most In 11 Months
Indian Rupee Rises To 3-day High Against U.S. Dollar
Sensex, Nifty End Marginally Higher After Early Losses
European Shares Mostly Higher Before BoE Rate Decision
Commodity Currencies Rise Amid Risk-On Mood, Strong China Export Data
Asian Shares End Mostly Higher As Trump's New Tariffs Go Into Effect
